Concepedia

Mallika Dhawan

MD

4

Publications

131

Citations

4

H-Index

2017

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Mallika Dhawan is an author at University of California, San Francisco specializing in pathology, medicine, and oncology.

Top concepts

MedicineOncologyPathologyCell BiologyTumor BiologyCancer ResearchPharmacologyMolecular OncologyDnaCell Death

Publications per year

2017–2021

4

Publications

4

Differential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors

Mallika Dhawan, Imke H. Bartelink, Rahul Aggarwal et al. · Clinical Cancer Research · 2017 · 76 citations · Full text

Phase 1 study of ANDES-1537: A novel antisense oligonucleotide against non-coding mitochondrial DNA in advanced solid tumors.

Mallika Dhawan, Rahul Aggarwal, Emily Boyd et al. · Journal of Clinical Oncology · 2018 · 23 citations

Dna, Chemoprevention Strategy, Molecular Biology +22

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors.

Benedito A. Carneiro, Ludimila Cavalcante, Bruno R. Bastos et al. · Journal of Clinical Oncology · 2020 · 17 citations

Color Perception, Pathology, Pharmacotherapy +18

512O Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies

Rahul Aggarwal, Sarah E. Umetsu, Mallika Dhawan et al. · Annals of Oncology · 2021 · 15 citations

Tumor Biology, Tumoral Pathology, Malignant Disease +8

Rows per page

1–4 of 4